Rankings
▼
Calendar
OMER
Omeros Corporation
$821M
Q1 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
-87.0% YoY
Gross Profit
$1M
87.2% margin
Operating Income
-$28M
-1743.6% margin
Net Income
-$30M
-1892.6% margin
EPS (Diluted)
$-0.62
QoQ Revenue Growth
-88.5%
Cash Flow
Operating Cash Flow
-$11M
Free Cash Flow
-$11M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$89M
Total Liabilities
$118M
Stockholders' Equity
-$29M
Cash & Equivalents
$1M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$12M
-87.0%
Gross Profit
$1M
$12M
-88.4%
Operating Income
-$28M
-$13M
-117.6%
Net Income
-$30M
-$15M
-99.2%
← FY 2018
All Quarters
Q2 2018 →
OMER Q1 2018 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena